Pfizer Inc

Common Name
Pfizer
Country
United States
Sector
Healthcare
Industry
Drug Manufacturers - General
Employees
81,000
Ticker
PFE
Exchange
NEW YORK STOCK EXCHANGE, INC.
Description
Pfizer Inc. is a multinational pharmaceutical and biotechnology corporation, recognized for its role in the research, development, and manufacturing of healthcare products. Operating in the health sec...

Pfizer Waste Data Preview

In 2023, Pfizer conducted an environmental assessment and disclosed corporate waste management data in accordance with recognized sustainability reporting standards. The company provided a breakdown of its waste by type (hazardous vs non-hazardous) and treatment method (recovery vs disposal), enabling greater transparency into its waste handling and environmental practices.

Metric (tonnes)2024202320222021 - 2017
Total Waste Generated
0000000
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
0000000
Total Waste Recovered
0000000
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
0000000
Total Hazardous Waste Generated
0000000
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
0000000
Non-Hazardous Waste Disposed
0000000
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
0000000

This table provides a simplified preview of selected waste data points. To access the complete dataset with full disclosures and structure, create a free account to purchase the full dataset.

Insights into Pfizer's Waste Treatment Practices

In 2023, Pfizer generated a total of 114,800 metric tonnes of waste.

Of this amount, 25.17% of Pfizer's total waste generated was recovered through methods such as recycling, reuse, or composting, while 74.76% was disposed of through landfilling, incineration, or combustion.

Pfizer's Waste Recovery Rate

25%

How much of Pfizer's waste is recycled or recovered?

In 2023, Pfizer reported a total waste generation of 114,800 metric tonnes, of which 25.17% was recovered through recycling, reuse, or composting. This moderate level of recovery indicates that Pfizer is taking steps toward improving its waste diversion practices, though there is still room to enhance recycling and recovery efforts.

Has Pfizer reduced its environmental waste footprint over time?

Since 2021, Pfizer's total waste generation increased by 1.59%, including a 3.61% increase in 2023, indicating a persistent upward trend that may reflect scaling operations, inefficiencies in resource use, or a lack of effective waste minimization practices.

Over the same period, Pfizer's waste recovery rate declined by 16.82%, yet improved by 7.28% in 2023, pointing to a recent rebound or renewed focus on better waste treatment outcomes.

Overall, Pfizer’s waste generation and recovery data show a mixed and inconsistent trend. A deeper analysis of the company's activities, industry benchmarks, and operational changes is needed to assess its sustainability performance more precisely.

Pfizer’s Waste Recovery vs. Disposal Over Time

202120222023030 k60 k90 k120 ktonnes
  • Total Waste Disposed
  • Total Waste Recovered

Insights into Pfizer’s Generation of Hazardous and Non-Hazardous Waste

In 2023, Pfizer generated a total of 114,800 metric tonnes of waste.

Of this amount, 69.6% of Pfizer's total waste generated of was classified as hazardous waste, characterized by properties such as toxicity, flammability, corrosiveness, or reactivity that may pose risks to human health, ecosystems, or the environment. 30.4% was identified as non-hazardous waste, generally considered less harmful and subject to lighter regulatory controls.

Pfizer’s Hazardous vs Non-Hazardous Waste Over Time

202120222023030 k60 k90 k120 ktonnes
  • Total Non-Hazardous Waste Generated
  • Total Hazardous Waste Generated

How Pfizer reduced the environmental impact of its waste?

Since 2021, Pfizer's total waste generation increased by 1.59%, including a 3.61% rise in 2023, reflecting a persistent upward trend that could be linked to operational growth, inefficient material use, or limited investment in waste prevention systems.

Over the same period, the share of hazardous waste increased by 4.72%, while holding steady in 2023, pointing to potential stagnation in efforts to reduce harmful waste types after a period of worsening performance.

Overall, Pfizer's waste and hazardousness trends are mixed or inconclusive. A more detailed review of its materials, industry standards, and operational changes would help clarify the net environmental impact of its waste strategy.

How does Pfizer treat its hazardous waste?

In 2023, Pfizer reported that 79,900 metric tonnes of its total waste output were classified as hazardous. This represents 69.6% of its overall waste generation.

The company treated this hazardous waste using a combination of methods. Approximately 12.89% was managed through recovery methods, indicating a moderate integration of circular practices into its hazardous waste management. However, a significant share was still directed toward disposal, highlighting room for improvement in reducing the long-term impact of hazardous materials.

Breakdown of Pfizer's Hazardous and Non-Hazardous Waste by Treatment Method

Hazardous WasteDisposed(60.6%)Hazardous WasteRecovered(9.0%)Non-Hazardous WasteDisposed(14.2%)Non-Hazardous WasteRecovered(16.2%)
Want Full Access to Pfizer's Waste Management Dataset?
Sign Up